The effects of low carbohydrate and high protein diet on the anthropometric indices, blood pressure, metabolic factors, and hormones related to metabolism: A systematic review and meta-analysis [0.03%]
低碳水化合物和高蛋白饮食对体质指数、血压、代谢因素及与代谢相关激素的影响：系统评价和meta分析
Marziyeh Najafi,Zahra Hariri,Omid Nikpayam et al.
Marziyeh Najafi et al.
Background and aims: The present study aimed to show the pooled effect of a low-carbohydrate high-protein diet (LCHPD) as a practical dietary approach on metabolic factors and anthropometric variables. ...
Prevalence of isolated nocturnal hypertension among patients with type 2 diabetes mellitus [0.03%]
2型糖尿病患者孤立性夜间高血压的患病率
Walter Gaston Espeche,Gustavo Cerri,Julian Minetto et al.
Walter Gaston Espeche et al.
Objective: To determine the prevalence of isolated nocturnal hypertension (INH) in patients with type 2 diabetes (T2D), and secondarily, to assess its frequency in those with normal office blood pressure and not receiving...
Authors' Reply to Letter to the Editor by Emily N.C. Manoogian et al [0.03%]
致Emily N.C. Manoogian等人信的回复
Meng Chen,Lan Xu,Victor W Zhong
Meng Chen
Association of sucralose consumption with insulin response and sensitivity [0.03%]
甜味剂三氯蔗糖的消费与胰岛素分泌和敏感性之间的关联研究
Shada Kodumayil,Ahmed Gebril,Soumya Nair et al.
Shada Kodumayil et al.
Background and aim: Use of non-nutritive sweeteners (NNS) is widespread in foods and beverages and are believed to have little to no impact on glucose metabolism. Nonetheless, recent studies have shown sucralose may not b...
Response to letter to the editor by Mondal H et al. "Delayed breakfast in type 2 diabetes: Critical gaps and translation barriers" [0.03%]
二型糖尿病延迟早餐研究的回信——尚未解决的关键问题及转化障碍
Ana Paula Bravo-Garcia,Evelyn B Parr
Ana Paula Bravo-Garcia
Impact of sodium-glucose co-transporter-2 inhibitor combined with mineralocorticoid receptor antagonist therapy versus either agent alone in individuals with chronic kidney disease: A systematic review and meta-analysis [0.03%]
钠葡萄糖协同转运蛋白-2抑制剂与盐皮质激素受体拮抗剂单用或联用治疗慢性肾脏病的系统评价和.meta.分析
Deep Dutta,A B M Kamrul-Hasan,Sweekruti Jena et al.
Deep Dutta et al.
Background: Sodium-glucose co-transporter-2 inhibitor (SGLT2i) with mineralocorticoid receptor antagonist (MRA) combination therapy (SMCT) hypothetically appears feasible and rational, given their complementary mechanisms...
Low dose pioglitazone (7.5 mg) provides efficacious glycemic control in Asian Indian patients with poorly controlled diabetes compared to 15 mg: A pilot randomized controlled parallel-group open-label trial over 12 months [0.03%]
小剂量吡格列酮（7.5毫克）疗效研究：与15毫克剂量相比，7.5毫克剂量可有效控制印度亚洲糖尿病患者血糖：一项随机对照、开放标签、平行分组试验一年的结果
Rohit Barnabas,Shruti Bhide,Saba Samad Memon et al.
Rohit Barnabas et al.
Aims: We aimed to compare the 1-year efficacy and safety of 7.5 mg versus 15 mg pioglitazone in Asian Indian patients with type 2 diabetes due to lack of long-term data in lower doses. ...
Gliclazide in type 2 diabetes: Cost-effective and clinically relevant in resource-limited settings [0.03%]
二甲双胍在2型糖尿病中的应用：在资源有限的情况下具有成本效益和临床意义
Banshi Saboo,Nitin Kapoor,Balaji Jaganmohan et al.
Banshi Saboo et al.
Burden and trends of diabetic kidney disease in East Asia, 1990-2038: An analysis of the global burden of disease study 2023 [0.03%]
东亚地区1990年至2038年糖尿病肾病的疾病负担及趋势：基于全球疾病负担研究2023的数据分析
Shuai Lin,Ruxin Liu,Guodong Zhong et al.
Shuai Lin et al.
Aim: Diabetic kidney disease is a major cause of chronic and end-stage kidney disease. East Asia, home to one-third of the world's people living with diabetes, is undergoing rapid demographic and metabolic transitions. ...
Experience with insulin detemir for type 2 diabetes in older people and people with comorbidities [0.03%]
二甲双胍治疗老年患者和合并症患者的2型糖尿病的经验
Melanie J Davies,Amra Ciric Alibegovic,Anders Boeck Jensen et al.
Melanie J Davies et al.
Aims: This real-world study assessed glycemic levels and further clinical outcomes, following initiation of detemir, in sub populations of people with T2D vulnerable to hypoglycemia. ...